| 产品名称 | RD 162 |
| 产品货号 | Axon 1532 CAS [915087-27-3] MF C22H16F4N4O2SMW 476.45 Purity: 98% Soluble in DMSO Description An orally active and very potent antagonist of androgen receptor (AR); Second-generation of antiandrogen for the treatment of advanced prostate cancer; highly recommended tool in AR research References Certificates Categories Extra info C Tran et al. Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science 2009, 324 (5928), 787-790. C Harrison. Anticancer drugs: New approaches to anti-androgen activities. Nature Reviews Drug Discovery 2009, 8, 452-453. CJ Hoimes and WK Kelley. Redefining hormone resistance in prostate cancer. Ther Adv Med Oncol. 2010, 2(2), 107–123. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Endocrinology Androgen (AR) NR3C Androgen receptor (AR) antagonist Chemical name 4-[7-(4-Cyano-3-trifluoromethyl-phenyl)-8-oxo-6-thioxo-5,7-diaza-spiro[3.4]oct-5-yl]-2-fluoro-N-methyl-benzamide Parent CAS No. [915087-27-3] Order Size Unit Price Stock 5 mg €125.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
RD 162Axon 1532 CAS [915087-27-3] MF C22H16F4N4O2S
Description
An orally active and very potent antagonist of androgen receptor (AR); Second-generation of antiandrogen for the treatment of advanced prostate cancer; highly recommended tool in AR research
Androgen receptor (AR) antagonist
Chemical name4-[7-(4-Cyano-3-trifluoromethyl-phenyl)-8-oxo-6-thioxo-5,7-diaza-spiro[3.4]oct-5-yl]-2-fluoro-N-methyl-benzamide Parent CAS No.[915087-27-3] |
| 产品资料 |
